Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jorge Aparicio

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group studyJorge Aparicio, José R Germà, Xavier García del Muro, et al.
European Urology Focus|July 30, 2017
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell CancerEnrique González-Billalabeitia, Juan Manuel Sepúlveda, Pablo Maroto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-UpCarlos Fernández-Martos, Jorge Aparicio, Carles Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I SeminomaStefanie Fischer, Torgrim Tandstad, Matthew Wheater, et al.
Clinical Colorectal Cancer|March 17, 2012
Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive TumorsManuel Benavides, Carles Pericay, Manuel Valladares-Ayerbes, et al.
British Journal of Cancer|June 2, 2026
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors studyMichal Mego, Edgar Israelyan, Robert J Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer GroupDarren R Feldman, Anja Lorch, Andrew Kramar, et al.
Clinical Colorectal Cancer|June 22, 2019
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)Rachel P Riechelmann, Vichien Srimuninnimit, Roberto Bordonaro, et al.
Cancers|August 19, 2020
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET StudyRuth Vera, María Luisa Gómez, Juan Ramón Ayuso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I NonseminomaStefanie Fischer, Torgrim Tandstad, Gabriella Cohn-Cedermark, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 2, 2005
Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group studyJorge Aparicio, José R Germà, Xavier García del Muro, et al.
European Urology Focus|July 30, 2017
Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell CancerEnrique González-Billalabeitia, Juan Manuel Sepúlveda, Pablo Maroto, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 24, 2004
Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: a phase II multicenter study with 3 years' follow-UpCarlos Fernández-Martos, Jorge Aparicio, Carles Bosch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 29, 2016
Outcome of Men With Relapse After Adjuvant Carboplatin for Clinical Stage I SeminomaStefanie Fischer, Torgrim Tandstad, Matthew Wheater, et al.
Clinical Colorectal Cancer|March 17, 2012
Oxaliplatin in combination with infusional 5-fluorouracil as first-line chemotherapy for elderly patients with metastatic colorectal cancer: a phase II study of the Spanish Cooperative Group for the Treatment of Digestive TumorsManuel Benavides, Carles Pericay, Manuel Valladares-Ayerbes, et al.
British Journal of Cancer|June 2, 2026
Risk factors and causes of early death in germ cell tumors: a Global Society for Rare GU tumors studyMichal Mego, Edgar Israelyan, Robert J Hamilton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 14, 2015
Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer GroupDarren R Feldman, Anja Lorch, Andrew Kramar, et al.
Clinical Colorectal Cancer|June 22, 2019
Aflibercept Plus FOLFIRI for Second-line Treatment of Metastatic Colorectal Cancer: Observations from the Global Aflibercept Safety and Health-Related Quality-of-Life Program (ASQoP)Rachel P Riechelmann, Vichien Srimuninnimit, Roberto Bordonaro, et al.
Cancers|August 19, 2020
Correlation of RECIST, Computed Tomography Morphological Response, and Pathological Regression in Hepatic Metastasis Secondary to Colorectal Cancer: The AVAMET StudyRuth Vera, María Luisa Gómez, Juan Ramón Ayuso, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 27, 2019
Outcome of Men With Relapses After Adjuvant Bleomycin, Etoposide, and Cisplatin for Clinical Stage I NonseminomaStefanie Fischer, Torgrim Tandstad, Gabriella Cohn-Cedermark, et al.
Pageof 10